| Dec 5 2022 |
Learnings from Recent Physician Practice Private Equity Transactions |
Foley & Lardner LLP |
| Dec 5 2022 |
Group Home Owners Sentenced in $1 Million Medicare Fraud Scheme |
The U.S. Department of Justice |
| Dec 5 2022 |
U.S. Continues to Require Proof of COVID-19 Vaccination for Foreign National Air Passengers |
Jackson Lewis P.C. |
| Dec 5 2022 |
HHS Warns HIPAA Covered Entities and Business Associates That Use of Website Cookies, Pixels and Other Tracking Technology May Violate HIPAA Rules |
Epstein Becker & Green, P.C. |
| Dec 3 2022 |
2023 Physician Fee Schedule Final Rule Supports Health Equity Through Investments in Accountable Care Organizations |
Epstein Becker & Green, P.C. |
| Dec 2 2022 |
Proposal to Overhaul Privacy Law Governing Substance Use Disorder Treatment Records |
Sheppard, Mullin, Richter & Hampton LLP |
| Dec 2 2022 |
No More Surprise Medical Bills: Providers Again Challenge No Surprises Act Rulemaking |
ArentFox Schiff LLP |
| Dec 1 2022 |
Key Changes to the Medicare Shared Savings Program |
Robinson & Cole LLP |
| Dec 1 2022 |
Podcast: Post-Dobbs: Access to Reproductive Health Care and Abortion-Inducing Drugs – Diagnosing Health Care |
Epstein Becker & Green, P.C. |
| Dec 1 2022 |
Medicare Hospital Outpatient Prospective Payment System (HOPPS) and Physician Fee Schedule (PFS) Final Rules Released; What Pharma Needs to Know |
ArentFox Schiff LLP |
| Nov 30 2022 |
Finding Our Way Out of the Pandemic Haze: What Telehealth Tools Are Medicare Providers Allowed to Keep, and Which Must They Leave Behind? |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 30 2022 |
New Year, New Laws: Changes to New York Health Care Provider Staffing Laws Taking Effect in January 2023 |
Mintz |
| Nov 30 2022 |
CMS Finalizes Changes for Telehealth Services for 2023 |
Foley & Lardner LLP |
| Nov 30 2022 |
FDA Lightens Promotional Restrictions for Certain COVID-19 Drugs with Emergency Use Authorization |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 30 2022 |
HHS Proposes Rule to Align Part 2 Records and HIPAA |
Robinson & Cole LLP |
| Nov 30 2022 |
New Challenge to Abortion Access Takes on FDA Drug Approvals |
ArentFox Schiff LLP |
| Nov 30 2022 |
HHS Proposes to Align Federal Substance Use Disorder Law with HIPAA |
Foley & Lardner LLP |
| Nov 29 2022 |
Medicare Remote Therapeutic Monitoring: Top FAQs for 2023 |
Foley & Lardner LLP |
| Nov 29 2022 |
The Information Blocking Rule's "Glide Path" - Compliance with the Information Blocking Rule After the Limitation on the Scope of EHI is Lifted [PODCAST] |
K&L Gates LLP |
| Nov 29 2022 |
DOJ Prosecutes Physician and Pharmaceutical Sales Representative for Criminal HIPAA Scheme |
ArentFox Schiff LLP |
| Nov 28 2022 |
DOJ Charges 10 Defendants for Allegedly Defrauding Public and Private Health Insurers Out of $11.1 Million Through Business Email Compromise Schemes |
Mintz |
| Nov 28 2022 |
As We Approach 2023, Where are We With COVID and the Workplace? |
Foley & Lardner LLP |
| Nov 28 2022 |
Key Takeaways from the HLTH 2022 Conference |
Foley & Lardner LLP |
| Nov 28 2022 |
Wondering if Your Digital Health Product or Service is Subject to FDA Regulations? |
Foley & Lardner LLP |
| Nov 23 2022 |
Health Care Organizations Warned of Venus Ransomware |
Robinson & Cole LLP |
| Nov 23 2022 |
CMS Issues Calendar Year 2023 Home Health Final Rule |
Robinson & Cole LLP |
| Nov 23 2022 |
Understanding the Medicare Overpayment Appeals Process |
Nelson Mullins |
| Nov 22 2022 |
Pharmacy Benefit Manager Reform Remains Legislative Priority |
ArentFox Schiff LLP |
| Nov 22 2022 |
Health Care Workforce Shortages Persist in Massachusetts and the United States |
Mintz |
| Nov 22 2022 |
Senate Approves Resolution to End COVID-19 National Emergency Declaration |
McDermott Will & Schulte LLP |
| Nov 21 2022 |
Pharmaceutical Manufacturers Ask EDVa to Allow Cost-Sharing Under the AKS |
Sheppard, Mullin, Richter & Hampton LLP |
| Nov 21 2022 |
B.S.ing with Mark Zemelman [PODCAST] |
Major Lindsey & Africa |
| Nov 21 2022 |
Medicare Advantage Programs’ Increasing Popularity Invites Heightened FCA and Regulatory Scrutiny |
Bradley Arant Boult Cummings LLP |
| Nov 21 2022 |
Federal District Court Certifies Transgender Discrimination Class Action Against Third-Party Administrator Under the Affordable Care Act |
ArentFox Schiff LLP |
| Nov 21 2022 |
Maryland and Missouri Pass Recreational Marijuana, Missouri Adds Medical Marijuana Cardholder Employment Protections |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
